PERNELL NANCE: Open Payments
NPI 1497397129 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 53 payments from 11 companies in 2025. Trend: 2023 $18 · 2024 $176 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $204 |
| Janssen Pharmaceuticals, Inc | 8 | $163 |
| E.R. Squibb & Sons, L.L.C. | 8 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $136 |
| Teva Pharmaceuticals USA, Inc. | 3 | $133 |
| Neurocrine BioSciences, Inc. | 5 | $114 |
| Alkermes, Inc. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 4 | $64 |
| Tris Pharma Inc | 1 | $63 |
| Lundbeck LLC | 3 | $57 |
Products named: INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY, CAPLYTA, UZEDY, INGREZZA, Dyanavel XR, VRAYLAR.
Industry payments across VA — which companies pay providers there.
